Parkinson’s disease in Middle East, North Africa and South Asia: Consensus from the MDS Task Force on the Middle East
Objective: To create a list of needs and priorities in the advancement of the Movement Disorders field in general and Parkinson’s disease care in specific…Wearable versus marker-free technologies: does it matter for clinical gait analysis?
Objective: To compare wearable sensor-based and marker-less 3D video-based gait analysis in two neurodegenerative disorders associated with gait dysfunction. Background: Quantitative gait analysis supports diagnosis…Effect of Medication Review on Reported Symptoms in Parkinson’s disease Patients
Objective: The objective was to analyse the effect of structured medication reviews (MR) in ambulatory PD patients on patient reported outcome measures (PROMS). Background: Patients…Сhange In The Body Composition Of Patients With Parkinsonism For 2 Years
Objective: The body composition of Parkinson’s disease patients is undergoing changes due to less physical activity, stress. Background: To determine the changes in body structure…Improving outcomes in hospitalized Parkinson’s patients
Objective: Evaluate an inpatient intervention to reduce rates of hospital related complications in hospitalized patients with Parkinson’s disease (PD). Background: Several interventions have been suggested…Characteristics and outcome of patients with Parkinson’s disease admitted to intensive care unit
Objective: To study the characteristics and the outcome of patients with Parkinson's disease admitted to intensive care unit. Background: Whereas Parkinson’s disease is associated with…Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations
Objective: To investigate the use of PBMCs as a biomarker of mitochondrial dysfunction in Parkinson disease (PD) patients carrying pathogenic parkin or LRRK2 mutations. Background:…Genomic variants associated with cognitive impairment in Parkinson’s disease: Ethnicity-specific GWAS
Objective: We aimed to identify the genomic variants that are associated with cognitive impairment in patients with Parkinson’s disease (PD). Background: Cognitive impairment is an…Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice
Objective: To describe and compare characteristics of African American (AA) and White Parkinson’s Disease (PD) patients seen in a large clinic practice at the University…Pattern and Presentation of Parkinson Disease in two Teaching Hospitals in Enugu, South East Nigeria
Objective: To describe the pattern of presentation of Parkinson disease in patients attending medical out-patient clinic in Enugu South East Nigeria. Background: Parkinson Disease is…
- « Previous Page
- 1
- …
- 211
- 212
- 213
- 214
- 215
- …
- 217
- Next Page »